Unknown

Dataset Information

Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke.


ABSTRACT:

Background and purpose

Factor Xa inhibitors are prescribed for stroke prevention in atrial fibrillation. Managing such patients is challenging especially if they are eligible for thrombolysis because there is no rapidly available test to detect the effect of such medications. Thrombelastography analyzes the dynamics of coagulation and can be rapidly performed. We sought to determine whether thrombelastography can detect the anticoagulation effect of factor Xa inhibitors in patients with stroke.

Methods

Blood from 10 patients with stroke was analyzed by thrombelastography at baseline and 2 to 18 hours after rivaroxaban administration.

Results

Increased R, K, and δ were seen at 2, 4, and 6 hours, while G, maximum amplitude, α-angle, and LY30 were decreased. Baseline R w

SUBMITTER: Bowry R 

PROVIDER: S-EPMC3954973 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature